Adding the triglyceride-lowering medication icosapent ethyl cut the risk of a first stroke by an additional 36% in patients already taking statin medications to treat high cholesterol. In previous research, icosapent ethyl reduced the risk of major cardiovascular events. The prescription medication is a highly purified form of an omega-3 fatty acid. The study’s results do not apply to supplements available over-the-counter.